Compare Sony Group Corp (SONY) vs Tilray Brands Inc (TLRY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sony Group Corp vs Tilray Brands Inc — how do they compare? Sony Group Corp trades at $24.18 (market cap $136.87B), while Tilray Brands Inc trades at $3.54 (market cap $530.54M). The key difference: Sony Group Corp is far larger — about 258× Tilray Brands Inc's market cap, and Sony Group Corp pays a 0.66% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Sony Group Corp for 96 Days and Tilray Brands Inc for 31 Days on average.
| SONY | TLRY | |
|---|---|---|
Market Cap | $136.87B | $530.54M |
Volume | 5,364,503 | 9,099,075 |
Sector | Technology | Health |
52-Week High | $30.26 | $21.00 |
52-Week Low | $19.32 | $3.57 |
Typical Hold Time | 96 Days | 31 Days |
Enterprise Value | $134.77B | $684.46M |
Dividend Yield | 0.66% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Sony (SONY) trades at $24.24, up 3.06% with a bullish technical signal from moving averages. The company reported strong Q4 2025 and Q2 2026 earnings beats but missed Q1 2026 expectations. Revenue remains stable around $12.96T with improved net income of $1.14T in 2025, though 2026 projections show a net loss. Analyst consensus is strongly bullish with 11 buy ratings and no sell recommendations. Recent news highlights Sony's content strength and legal actions against AI copyright infringement.
Sony presents a mixed outlook with strong entertainment assets and improving cash flow offset by projected 2026 profitability challenges. The stock's current valuation metrics appear reasonable, but investors should monitor execution risks in content monetization and competitive pressures in the entertainment sector. The bullish analyst sentiment and technical momentum suggest near-term upside potential.
Tilray Brands (TLRY) trades at $3.50, down 5.79% on the day and near its 52-week low. The stock shows bearish technical signals with negative moving averages and recent earnings misses across four consecutive quarters. Despite revenue growth to $821 million in 2025, the company reported a substantial net loss of $2.19 billion, driven by impairment charges and high operating costs. Analyst sentiment remains cautious with 65% hold ratings, though the consensus price target of $65.01 suggests significant potential upside from current levels.
The outlook remains challenging with persistent profitability issues and negative cash flow from operations. Investment opportunity exists if Tilray can achieve projected 2026 revenue growth to $915 million and reduce losses. Key risks include ongoing operational inefficiencies, competitive pressures in the cannabis market, and regulatory uncertainty. The stock's current valuation at 0.44 P/S and 0.33 P/B may attract value investors betting on a turnaround.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Sony Group Corp
Sony Group is a conglomerate with consumer electronics roots, which not only designs, develops, produces, and sells electronic equipment and devices, but also is engaged in content businesses, such as console and mobile games, music, and movies. Sony is a global top company of CMOS image sensors, game consoles, professional broadcasting cameras, and music publishing, and is one of the top players on digital cameras, wireless earphones, recorded music, movies, and so on. Sony's business portfolio is well diversified with six major business segments. The company fully consolidated Sony Financial in September 2020, which provides life and non-life insurance, banking, and other financial services.
Read more on SONY →About Tilray Brands Inc
Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →
